Pharmacogenomics of third-generation aromatase inhibitors.

Pharmacogenomics of third-generation aromatase inhibitors.

Item
http://www.wikidata.org/entity/Q38010777
Genotype, allele and haplotype frequencies of four TCL1A gene polymorphisms associated with musculoskeletal toxicity in the South Indian descent.Multivariate analysis to predict letrozole efficacy in improving sperm count of non-obstructive azoospermic and cryptozoospermic patients: a pilot study.Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.The future of pharmacogenetics for osteoporosis.Impact of metabolizing enzymes on drug response of endocrine therapy in breast cancer.Predictive markers in elderly patients with estrogen receptor-positive breast cancer treated with aromatase inhibitors: an array-based pharmacogenetic study.Treatment strategies for the infertile polycystic ovary syndrome patient.Haplotype structures and functional polymorphic variants of the drug target enzyme aromatase (CYP19A1) in South Indian population.The use of aromatase inhibitors in boys with short stature: what to know before prescribing?
P2860

Pharmacogenomics of third-generation aromatase inhibitors.

Item
http://www.wikidata.org/entity/Q38010777
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacogenomics of third-generation aromatase inhibitors.
@en
type
label
Pharmacogenomics of third-generation aromatase inhibitors.
@en
prefLabel
Pharmacogenomics of third-generation aromatase inhibitors.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Pharmacogenomics of third-generation aromatase inhibitors.
@en
P2093
P2860
P304
P31
P356
10.1517/14656566.2012.687721
P407
P433
P478
P577
P698
P921